Total Funding
18
30
Total FundingPost-IPO Equity raised
Growth Score 18 in past quarter
-4 pts
Heat Score 30 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
279719
Cotinga Pharmaceuticals discovers and develops drug therapies for diseases.
- Gene Kelly: CFO
Wayne Danter: Founder, President & CEO
About the Company
Critical Outcome Technologies Inc. (COTI) believes that there must be a better way to get safe and effective new drug therapies to people in need on a more timely, cost effective and efficient manner.
Their business is disease-specific drug discovery, optimization and pre-clinical development using a specially developed series of computer
models. COTI is focused on the discovery and pre-clinical development of small molecules for the treatment of serious diseases for which current therapy is either lacking or ineffective.